VICTORIA, BC, Oct. 15 /CNW/ - Aspreva Pharmaceuticals Corporation
(NASDAQ: ASPV; TSX: ASV), a pharmaceutical company focused on increasing the
pool of evidence-based medicines available for patients living with less
common diseases, announced today that the company will release financial and
business results for the third quarter ending September 30, 2007 on Wednesday,
Aspreva will host a conference call to discuss results for the third
quarter 2007 on Wednesday, October 31, 2007 at 2:00 p.m. Pacific Time
(5:00 p.m. Eastern Time).
North America (toll free): 1-866-202-0886
Enter passcode: 14829169
The call will be available for replay until Wednesday, November 7th, by
calling 1-888-286-8010 (North America) or 1-617-801-6888 (International) and
entering the pass code 79726236.
A live webcast will also be available to all interested parties on
Aspreva's website: www.aspreva.com. Please click on the "Webcasts and Events"
link under the Investors section. A replay of the webcast will be available
until the Company's fourth quarter 2007 conference call.
About Aspreva Pharmaceuticals
Aspreva is a global pharmaceutical company focused on identifying,
developing, and, upon approval, commercializing evidence-based medicines for
patients living with less common diseases. Aspreva common stock is traded on
the NASDAQ Global Select Market under the trading symbol "ASPV" and on the
Toronto Stock Exchange under the trading symbol "ASV". Learn more at
For further information:
For further information: Sage Baker, VP, Investor Relations & Corporate
Communications, Aspreva Pharmaceuticals, (250) 744-2488 ext. 84270,